The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

Popular brands such as Ozempic, Wegovy and Mounjaro were initially approved by the U.S. Food and Drug Administration to ...

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...